Coagulation Factor XIII A-Subunit (Recombinant), also known as catridecacog, is a recombinant form of the Factor XIII-A2 homodimer composed of two factor XIII (FXIII) A-subunits . For people with congenital deficiency or mutation of Factor XIII, a rare bleeding disorder, exogenous replacement of this key coagulation factor is essential for management and pre...
For routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.